Table 7.
Effect of encapsulated L-Lys-HCl and DL-Met supplementation on the gene expression of amino acid transporters in different sections of intestinal tract1,2
| Item | Control | 80CLM | 60CLM | P-value |
|---|---|---|---|---|
| Duodenum | ||||
| b 0,+ AT | 1.00 ± 0.07 | 1.05 ± 0.12 | 1.12 ± 0.13 | 0.756 |
| CAT-1 | 1.00 ± 0.16 | 0.94 ± 0.09 | 0.92 ± 0.11 | 0.900 |
| y + LAT1 | 1.00 ± 0.24 | 1.15 ± 0.18 | 0.90 ± 0.16 | 0.657 |
| B 0 AT | 1.00 ± 0.19 | 0.74 ± 0.15 | 0.72 ± 0.14 | 0.396 |
| rBAT | 1.00 ± 0.14 | 0.75 ± 0.07 | 0.80 ± 0.06 | 0.177 |
| EAAT3 | 1.00 ± 0.11 | 0.86 ± 0.06 | 0.97 ± 0.11 | 0.581 |
| PepT1 | 1.00 ± 0.14 | 0.80 ± 0.10 | 1.06 ± 0.16 | 0.306 |
| Jejunum | ||||
| b 0,+ AT | 1.00 ± 0.21 | 0.74 ± 0.09 | 0.91 ± 0.14 | 0.491 |
| CAT-1 | 1.00 ± 0.12 | 1.06 ± 0.14 | 0.92 ± 0.09 | 0.728 |
| y + LAT1 | 1.00 ± 0.17 | 1.15 ± 0.19 | 1.31 ± 0.23 | 0.548 |
| B 0 AT | 1.00 ± 0.18 | 1.10 ± 0.21 | 0.93 ± 0.17 | 0.816 |
| rBAT | 1.00 ± 0.11 | 0.80 ± 0.10 | 0.94 ± 0.24 | 0.665 |
| EAAT3 | 1.00 ± 0.22 | 0.67 ± 0.09 | 0.73 ± 0.09 | 0.260 |
| PepT1 | 1.00 ± 0.12 | 0.56 ± 0.12 | 0.94 ± 0.19 | 0.087 |
| Ileum | ||||
| b 0,+ AT | 1.00 ± 0.08 | 1.00 ± 0.10 | 0.90 ± 0.19 | 0.813 |
| CAT-1 | 1.00 ± 0.13 | 1.14 ± 0.21 | 1.01 ± 0.18 | 0.882 |
| y + LAT1 | 1.00 ± 0.23 | 1.08 ± 0.24 | 0.80 ± 0.09 | 0.545 |
| B 0 AT | 1.00 ± 0.16 | 1.19 ± 0.19 | 0.99 ± 0.16 | 0.697 |
| rBAT | 1.00 ± 0.09 | 0.98 ± 0.14 | 1.02 ± 0.16 | 0.979 |
| EAAT3 | 1.00 ± 0.11 | 0.91 ± 0.21 | 0.96 ± 0.19 | 0.932 |
| PepT1 | 1.00 ± 0.10 | 1.25 ± 0.13 | 1.04 ± 0.16 | 0.412 |
1Basal diet supplemented with encapsulated L-lys HCL and DL-met at 60% (60 CLM) or 80% (80CLM) of the control levels.
2Data were presented as the mean ± SD (n = 8).